David R. Gandara
Directeur/Membre du Conseil chez International Association for the Study of Lung Cancer
Profil
David R.
Gandara has been a Director of Response Genetics, Inc. since April 30, 2008 and Associate Director of Clinical Research and a Director of Thoracic Oncology for the University of California, Davis Cancer Center since 1994.
He is a Professor of Medicine for the University of California, Davis School of Medicine.
Dr. Gandara is a Director of International Association for the Study of Lung Cancer.
He was a Director, Secretary and Treasurer of the American Society for Clinical Oncology.
Dr. Gandara is Chairman of the NCI-directed Lung Correlative Science Committee.
He received an MD from the University of Texas Medical Branch and a BA from the University of Texas.
Postes actifs de David R. Gandara
| Sociétés | Poste | Début |
|---|---|---|
| International Association for the Study of Lung Cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de David R. Gandara
| Sociétés | Poste | Fin |
|---|---|---|
| RESPONSE GENETICS, INC | Directeur/Membre du Conseil | 19/01/2010 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Secrétaire Général | - |
Formation de David R. Gandara
| The University of Texas at Austin | Undergraduate Degree |
| University of Texas Medical Branch | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RESPONSE GENETICS, INC | Health Technology |
| Entreprise privées | 2 |
|---|---|
| International Association for the Study of Lung Cancer | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
